Versartis Selects Comprehend Systems
Biopharmaceutical company Versartis, Inc. has selected Comprehend Systems
Biopharmaceutical company Versartis, Inc. has selected Comprehend Systems to help facilitate compilation of real-time study information and subject data. Comprehend Clinical, a cloud-based platform that allows sponsors to access and analyze data from any clinical IT system.
Versartis is developing VRS-317, a novel, long-acting form of recombinant human growth hormone for the treatment of growth hormone deficiency (GHD). VRS-317 is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance and therefore treatment outcomes. The company is currently completing a Phase II clinical trial of VRS-317 in children with GHD.
Versartis selected Comprehend for its ability to provide real-time access to the data in its studies and to simplify what had been a time-consuming process managing multiple data sources. With Comprehend, the company’s clinical operations team has a complete view of every study and access to study information real-time via intuitive dashboards. And once created, those dashboards can be re-used and updated automatically.
Read the full release here.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
